374 related articles for article (PubMed ID: 7619797)
1. NMR studies of substrate binding to cytochrome P450 BM3: comparisons to cytochrome P450 cam.
Modi S; Primrose WU; Boyle JM; Gibson CF; Lian LY; Roberts GC
Biochemistry; 1995 Jul; 34(28):8982-8. PubMed ID: 7619797
[TBL] [Abstract][Full Text] [Related]
2. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
[TBL] [Abstract][Full Text] [Related]
3. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the interactions of cytochrome b5 with flavocytochrome P450 BM3 and its domains.
Noble MA; Girvan HM; Smith SJ; Smith WE; Murataliev M; Guzov VM; Feyereisen R; Munro AW
Drug Metab Rev; 2007; 39(2-3):599-617. PubMed ID: 17786641
[TBL] [Abstract][Full Text] [Related]
5. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
6. Imidazolyl carboxylic acids as mechanistic probes of flavocytochrome P-450 BM3.
Noble MA; Quaroni L; Chumanov GD; Turner KL; Chapman SK; Hanzlik RP; Munro AW
Biochemistry; 1998 Nov; 37(45):15799-807. PubMed ID: 9843385
[TBL] [Abstract][Full Text] [Related]
7. The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction.
Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
Nat Struct Biol; 1996 May; 3(5):414-7. PubMed ID: 8612070
[No Abstract] [Full Text] [Related]
8. Fatty acid-induced alteration of the porphyrin macrocycle of cytochrome P450 BM3.
Macdonald ID; Munro AW; Smith WE
Biophys J; 1998 Jun; 74(6):3241-9. PubMed ID: 9635777
[TBL] [Abstract][Full Text] [Related]
9. A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.
Modi S; Paine MJ; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
Biochemistry; 1996 Apr; 35(14):4540-50. PubMed ID: 8605204
[TBL] [Abstract][Full Text] [Related]
10. A single mutation in cytochrome P450 BM3 induces the conformational rearrangement seen upon substrate binding in the wild-type enzyme.
Joyce MG; Girvan HM; Munro AW; Leys D
J Biol Chem; 2004 May; 279(22):23287-93. PubMed ID: 15020590
[TBL] [Abstract][Full Text] [Related]
11. Engineering the substrate specificity of Bacillus megaterium cytochrome P-450 BM3: hydroxylation of alkyl trimethylammonium compounds.
Oliver CF; Modi S; Primrose WU; Lian LY; Roberts GC
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):537-44. PubMed ID: 9359427
[TBL] [Abstract][Full Text] [Related]
12. Phe393 mutants of cytochrome P450 BM3 with modified heme redox potentials have altered heme vinyl and propionate conformations.
Chen Z; Ost TW; Schelvis JP
Biochemistry; 2004 Feb; 43(7):1798-808. PubMed ID: 14967021
[TBL] [Abstract][Full Text] [Related]
13. Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3): resonance Raman spectral characterization of the heme domain and of the holoenzyme.
Hudeèek J; Baumruk V; Anzenbacher P; Munro AW
Biochem Biophys Res Commun; 1998 Feb; 243(3):811-5. PubMed ID: 9500975
[TBL] [Abstract][Full Text] [Related]
14. Cobaltocene-mediated catalytic monooxygenation using holo and heme domain cytochrome P450 BM3.
Udit AK; Arnold FH; Gray HB
J Inorg Biochem; 2004 Sep; 98(9):1547-50. PubMed ID: 15337607
[TBL] [Abstract][Full Text] [Related]
15. Are branched chain fatty acids the natural substrates for P450(BM3)?
Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
[TBL] [Abstract][Full Text] [Related]
16. Structural and spectroscopic characterization of P450 BM3 mutants with unprecedented P450 heme iron ligand sets. New heme ligation states influence conformational equilibria in P450 BM3.
Girvan HM; Seward HE; Toogood HS; Cheesman MR; Leys D; Munro AW
J Biol Chem; 2007 Jan; 282(1):564-72. PubMed ID: 17077084
[TBL] [Abstract][Full Text] [Related]
17. Rational re-design of the substrate binding site of flavocytochrome P450 BM3.
Ost TW; Miles CS; Murdoch J; Cheung Y; Reid GA; Chapman SK; Munro AW
FEBS Lett; 2000 Dec; 486(2):173-7. PubMed ID: 11113461
[TBL] [Abstract][Full Text] [Related]
18. Flavocytochrome P450 BM3 mutant A264E undergoes substrate-dependent formation of a novel heme iron ligand set.
Girvan HM; Marshall KR; Lawson RJ; Leys D; Joyce MG; Clarkson J; Smith WE; Cheesman MR; Munro AW
J Biol Chem; 2004 May; 279(22):23274-86. PubMed ID: 15020591
[TBL] [Abstract][Full Text] [Related]
19. Resonance Raman studies of cytochrome P450BM3 and its complexes with exogenous ligands.
Deng TJ; Proniewicz LM; Kincaid JR; Yeom H; Macdonald ID; Sligar SG
Biochemistry; 1999 Oct; 38(41):13699-706. PubMed ID: 10521277
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulations of P450 BM3--examination of substrate-induced conformational change.
Chang YT; Loew GH
J Biomol Struct Dyn; 1999 Jun; 16(6):1189-203. PubMed ID: 10447203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
